Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product

Author(s):  Chauhan Nikita N, Patel Jayvadan K

Issue:  Jan/Feb 2023 - Volume 27, Number 1
View All Articles in Issue

Page(s):  60-71

Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 1
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 2
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 3
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 4
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 5
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 6
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 7
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 8
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 9
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 10
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 11
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 12

Download in electronic PDF format for $75

Abstract:  The objective of this study was to prepare and evaluate ibuprofen nanocrystals using isopropyl alcohol and stabilizer sodium lauryl sulphate by way of the precipitation method. The nanocrystals were prepared by the bottom-up approach of the precipitation technique. This technique involves the use of an organic phase, which is completely miscible in the external aqueous phase. The ratio used for organic solvent-to-aqueous solvent was 1:50. The Fourier Transform Infrared Spectroscopy analyses confirmed that the drug and excipients were compatible, and the differential scanning calorimetry results indicated that the precipitation method led to no change in the crystalline structure of the drug. Scanning electron microscopy analysis of ibuprofen nanocrystals showed the promising size reduction of pure drug ibuprofen. Differential light scattering technique showed significant decrease in particle size and good stability of ibuprofen nanocrystals. Ibuprofen nanocrystals increased 20% to 25% of the saturation solubility of ibuprofen nanocrystals. Ibuprofen nanocrystals showed 90% drug release in the dissolution medium within 1 hour, while the pure drug and market product were dissolved only up to 58% and 63%, respectively. Ibuprofen nanocrystals increased the saturation solubility and in vitro dissolution of the drug as compared to conventional market product.

Related Keywords: ibuprofen nanocrystals, precipitation method, commercial ibuprofen, drug release, nonsteroidal anti-inflammatory drugs, NSAID, cyclooxygenase, aqueous solubility, solubility in water, drug absorption, bioavailability, drug dissolution, saturation solubility, stability testing, disintegration test, particle size, zeta potential, particle size reduction

Related Categories: PAIN MANAGEMENT, PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product
Chauhan Nikita N
, Patel Jayvadan K
Jan/Feb 2023
Pg. 60-71

Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Frankum James
, Ramsay Dale, Das Nandita G, Das Sudip K
Mar/Apr 2004
Pg. 101-105

Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules
Allen Loyd V Jr
May/Jun 2020
Pg. 227

Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 245

Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Allen Loyd V Jr
Jul/Aug 2020
Pg. 320

Ibuprofen 5% Topical Cream
Allen Loyd V Jr
May/Jun 2011
Pg. 244

Ibuprofen 5% Gel
Allen Loyd V Jr
Jan/Feb 2011
Pg. 66

Ibuprofen 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 67

Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Goodwin Donald A
, Fuhram L Clifton
Nov/Dec 1999
Pg. 496-500

Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base
Spennacchio Antonio
, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Jan/Feb 2023
Pg. 72-77

The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet
Alhmoud Hassan
, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
Sep/Oct 2023
Pg. 431-439

Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Allen Loyd V Jr
Nov/Dec 2023
Pg. 474-481

Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product
Allen Loyd V Jr
Jul/Aug 2004
Pg. 292-293

Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid
, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2017
Pg. 418-425

In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Kohan Hamed Gilzad
, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Mar/Apr 2021
Pg. 146-155

Ibuprofen 2% Topical Gel
Allen Loyd V Jr
Sep/Oct 2004
Pg. 388

Marketing Your Prescription Compounding Practice: Part One
Letendre William R
, Jackson Richard A
Jan/Feb 2000
Pg. 36-38

Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Taghi Hassanien Sagban
, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Jul/Aug 2023
Pg. 340-346

Determining the Availability of a Commercial Drug
Jan/Feb 2003
Pg. 44-45

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Return to Top